The Journal of the American Medical Association (JAMA) has published a Viewpoint, Major Challenges in Providing an Effective and Timely Pandemic Vaccine for Influenza A(H7N9), by Michael T. Osterholm, PhD, MPH, of the University of Minnesota, Minneapolis, and colleagues.
The emergence of avian influenza A(H7N9) virus in humans has public health authorities around the world on high alert for the potential development of a human influenza pandemic. As of May 8, 2013, authorities had identified 131 confirmed cases and 32 deaths among residents of 8 provinces and 2 municipalities in China, the authors write.
In this Viewpoint, the authors examine several issues regarding the A(H7N9) vaccines, including estimated effectiveness, timely availability and the regulatory approval process. To read the Viewpoint, CLICK HERE.
CDC Strategies Preventing Hospital-Onset C difficile Effectiveness Inconclusive in Testing
April 15th 2024Hospitals using CDC prevention strategies had different incidences of hospital-associated Clostridioides difficile infection compared to those that didn't, but the reasons are not necessarily the strategies themselves.